Amundi
NVCR icon

Amundi’s NovoCure NVCR Stock Holding History

Amundi’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$820K Buy
54,106
+6,523
+14% +$98.7K ﹤0.01% 1457
2026
Q1 		$519K Buy
47,583
+7,907
+20% +$98.8K ﹤0.01% 1537
2025
Q4 		$513K Buy
39,676
+3,940
+11% +$50.6K ﹤0.01% 1466
2025
Q3 		$518K Sell
35,736
-3,355
-9% -$44.8K ﹤0.01% 1318
2025
Q2 		$699K Buy
39,091
+39,041
+78,082% +$680K ﹤0.01% 1287
2025
Q1 		$849 Sell
50
-9
-15% -$204 ﹤0.01% 2058
2024
Q4 		$1.71K Buy
+59
New +$1.25K ﹤0.01% 2002
2024
Q1 		– Sell
-60,000
Closed -$884K – 2053
2023
Q4 		$884K Buy
+60,000
New +$803K ﹤0.01% 1349
2023
Q3 		– Sell
-81,944
Closed -$3.47M – 2049
2023
Q2 		$3.47M Sell
81,944
-140,754
-63% -$8.74M ﹤0.01% 1053
2023
Q1 		$13.8M Buy
222,698
+18,929
+9% +$1.51M 0.01% 771
2022
Q4 		$19.7M Buy
203,769
+19,184
+10% +$1.44M 0.01% 698
2022
Q3 		$15.7M Buy
184,585
+23,618
+15% +$1.84M 0.01% 742
2022
Q2 		$11.7M Buy
160,967
+79,567
+98% +$5.99M 0.01% 738
2022
Q1 		$7M Buy
81,400
+9,528
+13% +$702K ﹤0.01% 896
2021
Q4 		$5.01M Buy
71,872
+2,842
+4% +$285K ﹤0.01% 996
2021
Q3 		$8.02M Buy
69,030
+11,940
+21% +$1.81M 0.01% 898
2021
Q2 		$12.7M Buy
+57,090
New +$11.1M 0.01% 780

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Amundi's NVCR Position: Q2 2026 in Review

Amundi increased its NovoCure (NVCR) stake by 14% in Q2 2026, buying an estimated $98.7K and bringing the position to 54,106 shares worth $820K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Amundi first reported a position in NVCR in Q2 2021 and has held it in 17 quarters since. The position peaked at $19.7M in Q4 2022. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Amundi held 54,106 shares of NovoCure worth $820K as of Q2 2026.
  • Amundi bought 6,523 NovoCure shares in Q2 2026, an estimated $98.7K.
  • NovoCure made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1457 holding.
  • Amundi first reported a position in NovoCure in Q2 2021 and has held it in 17 quarters since.
  • Amundi's NovoCure position peaked at $19.7M in Q4 2022.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.